HCSGNasdaqServices-Nursing & Personal Care FacilitiesFiscal year ends December 31
HEALTHCARE SERVICES GROUP INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 24, 2026
$21.11−0.02 (-0.09%)
Close on Oct 19, 2026
- Market cap
- $1.48B
- P/E (TTM)
- 12.3
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
13.0%−2.2 pts over 5 years
Net margin
3.2%−2.4 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +7.1% | +2.8% | +0.9% | +2.5% | |
| Gross profit | +5.0% | +7.4% | -2.2% | +1.8% | |
| Net income | +49.6% | +19.9% | -9.8% | +0.2% | |
| EPS, diluted | +52.8% | +20.8% | -9.3% | +0.1% | |
| Free cash flow | +468.7% | – | -8.2% | +9.1% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 24.4% | 21.2% | 11.7% | |
| Return on assets | 15.3% | 13.1% | 7.4% | |
| Current ratio | 4.11 | 3.53 | 3.38 | |
| Capex to revenue | 0.3% | 0.2% | 0.3% | |
| Diluted shares | 73M | 75M | 73M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Healthcare Services generated $264.54M from operations and spent $253.48M on capital expenditure, dividends and share buybacks. 11% of that went back into the business.
Generated
$264.54M
Used
$253.48M
Capital expenditure$28.46M11%Dividends$125.60M50%Share buybacks$99.42M39%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin3.2%
×Asset turnover2.30×
×Equity multiplier1.58×
=Return on equity, FY202511.7%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 3.2% | 2.30× | 1.58× | 11.7% |
| FY2024 | 2.3% | 2.15× | 1.67× | 8.3% |
| FY2023 | 2.3% | 2.21× | 1.73× | 8.8% |
| FY2022 | 2.0% | 2.25× | 1.74× | 7.9% |
| FY2021 | 3.0% | 2.10× | 1.71× | 10.6% |
| FY2020 | 5.6% | 2.34× | 1.62× | 21.2% |
| FY2019 | 3.5% | 2.60× | 1.57× | 14.3% |
| FY2018 | 4.2% | 2.93× | 1.63× | 19.9% |
| FY2017 | 4.7% | 3.09× | 1.63× | 23.9% |
| FY2016 | 5.0% | 3.10× | 1.59× | 24.4% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
7of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero$59.06M
- Cash generatingOperating cash flow above zero$144.97M
- Return on assets improvedROA up on the prior year5.0% → 7.4%
- Earnings backed by cashOperating cash flow above net income$144.97M vs $59.06M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose2.89 → 3.38
- No dilutionShare count did not rise74M → 73M
- Gross margin improvedGross margin up on the prior year13.29% → 13.03%
- More efficientAsset turnover rose2.17 → 2.29